Literature DB >> 17280750

Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.

Giuliano Da Villa1, Luisa Romanò, Alessio Sepe, Raffaele Iorio, Nunzio Paribello, Alessandra Zappa, Alessandro R Zanetti.   

Abstract

The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing pattern of HBV infection in a former hyperendemic area (Afragola, South Italy), and to assess the long-term persistence of anti-HBs in two cohorts of individuals vaccinated as infants 18 and 23 years ago. Our data shows a significant decline in the prevalence of hepatitis B virus (HBV) markers in the general population from 1978 to 2006 (HBsAg: 13.4% versus 0.91%; anti-HBc: 66.9% versus 7.6%; p<0.001). Data from two cohorts of vaccinees provides further evidence regarding the long-term persistence of vaccine-induced anti-HBs. Data here reported indicates that the implementation of vaccination had a great impact in the control and prevention of hepatitis B in Italy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280750     DOI: 10.1016/j.vaccine.2007.01.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

Review 1.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

2.  Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study.

Authors:  Yan Qiu; Jing-Jing Ren; Zi-Kang Wu; Ling-Zhi Shen; Huan Shan; Xue-Wei Dai; Jing Li; Ying Liu; Wen Ren; Jun Yao; Lan-Juan Li
Journal:  Hum Vaccin Immunother       Date:  2020-05-19       Impact factor: 3.452

3.  Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.

Authors:  Massimo De Paschale; Maria Teresa Manco; Luisa Belvisi; Bruno Brando; Stefania Latella; Carlo Agrappi; Paola Mirri; Arianna Gatti; Pierangelo Clerici
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

Review 4.  Hepatitis B vaccination.

Authors:  Luisa Romanò; Sara Paladini; Cristina Galli; Giovanni Raimondo; Teresa Pollicino; Alessandro R Zanetti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

5.  Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.

Authors:  Sara Boccalini; Elettra Pellegrino; Emila Tiscione; Giovanna Pesavento; Angela Bechini; Miriam Levi; Stefano Rapi; Stefano Mercurio; Francesco Mannelli; Marta Peruzzi; Cesare Berardi; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-01-25       Impact factor: 3.452

Review 6.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China.

Authors:  Lijie Yu; Jian Wang; Dawei Zhu; Anli Leng; Knut R Wangen
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

8.  Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.

Authors:  M Fasano; A Saracino; G Carosi; F Mazzotta; N Marino; E Sagnelli; G B Gaeta; G Angarano; G Verucchi; P Bellissima; C Angeletti; T Santantonio
Journal:  Infection       Date:  2012-12-21       Impact factor: 3.553

Review 9.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 10.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.